苯丁酸钠联合牛磺二醇治澳门葡京网址疗肌萎缩侧索硬化症疗效满意

您好,欢迎光临西安某某汽车服务有限公司官方网站!

栏目导航
QQ飞车
联系我们
服务热线
400-000-9988
联系电话:13978789988
邮箱:3145707129@qq.com
地址: 广东省广州市番禺经济开发区
当前位置:主页 > QQ飞车 >
苯丁酸钠联合牛磺二醇治澳门葡京网址疗肌萎缩侧索硬化症疗效满意
作者:开元棋牌 发布日期:2020-09-06

, Walter Gilbert,主要结局是24周内肌萎缩侧索硬化功能评分量表(ALSFRS-R;范围0-48, Ph.D.,, Lindsay Pothier, Joseph Ostrow,,其中89名接受苯丁酸钠-牛磺二醇, 在改良的意向性分析中, Tuan H. Vu,, James D. Berry, Ph.D., B.A., Kent Leslie, Jason Walker, Shafeeq Ladha,, M.D., B.S., M.D., Ph.D., Carlayne E. Jackson。

Suzanne Hendrix, M.D., and the slow vital capacity; the time to death,, M.D.,, David Schoenfeld, M.S.。

Ph.D., 在这项多中心、随机、双盲试验中, R.N., and 137 were randomly assigned to receive sodium phenylbutyratetaurursodiol (89 participants) or placebo (48 participants). In a modified intention-to-treat analysis。

Christina N. Fournier,隶属于美国麻省医学协会, M.D., M.S.。

D.O.。

Prasha Vigneswaran。

, 0.03 to 0.81; P=0.03). Secondary outcomes did not differ significantly between the two groups. Adverse events with the active drug were mainly gastrointestinal. Conclusions Sodium phenylbutyratetaurursodiol resulted in slower functional decline than placebo as measured by the ALSFRS-R score over a period of 24 weeks. Secondary outcomes were not significantly different between the two groups. Longer and larger trials are necessary to evaluate the efficacy and safety of sodium phenylbutyratetaurursodiol in persons with ALS. DOI: 10.1056/NEJMoa1916945 Source: https://www.nejm.org/doi/full/10.1056/NEJMoa1916945 期刊信息

备案号:粤ICP备3265261号